Latest Market News

Golden Deeps Ltd reports outstanding high-grade copper, silver, and critical metals results from its Central Otavi Project in Namibia, alongside a $3.54 million capital raise to fund ongoing exploration.

Ovanti Limited advances its U.S. buy now, pay later ambitions through strategic partnerships and a proposed Nasdaq listing valued at US$300 million.

Northern Minerals has made significant strides in developing its Browns Range Heavy Rare Earths Project, securing substantial funding support from US and Australian agencies alongside a $60.5 million capital raise. Exploration success and engineering progress position the company for a Final Investment Decision by late 2026.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.

Minbos Resources advances key financing deals and unveils a cost-cutting plan for its Cabinda Phosphate Project, while forming a strategic joint venture to develop green ammonia production targeting 2028.

Audio Pixels Holdings has locked in a $6 million unsecured loan facility from an investor linked to its chairman, with conversion to notes contingent on shareholder approval and company milestones.

Ragnar Metals has confirmed impressive high-grade gold assays at its Harnäs Gold Project in Sweden, paving the way for maiden diamond drilling in early 2026. Strategic investments in Australian gold producers further bolster its diversified portfolio amid record gold prices.

Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.

Gullewa Limited has increased its ownership in Central Iron Ore Limited to a controlling 70.5% by subscribing to a recent rights issue, acquiring over 23 million new shares.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

Clime Investment Management appoints John Abernethy as Director of Investments, signalling a renewed focus on investment philosophy and client outcomes. Despite fund closures and regulatory challenges, the company reports improved fund returns and a promising interim profit outlook.

Adherium Limited has exceeded its 2025 shipment goals for its Hailie Smartinhaler devices, driven by rapid growth in remote patient monitoring activations and improved US Medicare reimbursement policies.